SARS-CoV-2 (COVID-19) Membraanantilichaam (biotine)

Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak (1) . SARS-CoV-2 is the seventh member of the enveloped, positive-stranded RNA viruses that are able to infect humans. The SARS-CoV-2 genome, like other coronaviruses, encodes for multiple structural and nonstructural proteins. The structural proteins include spike protein (S), envelope protein (E), membrane glycoprotein (M), nucleocapsid phosphoprotein (N), and the nonstructural proteins include open reading frame 1ab (ORF1ab), ORF3a, ORF6, ORF7a, ORF8, and ORF10 (2) .The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope (3) . It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design (4) .

43740571

P0DTC5

QJW69073

Virus

9157

Biotin

Primary Antibodies

Infectious Disease, COVID-19

SARS-CoV-2 (COVID-19) Membrane Antibody is affinity chromatography

1 mg/mL

Predicted reactivity based on immunogen sequence: SARS-CoV Matrix protein: (100%)

SARS-CoV-2 (COVID-19) Membrane Antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

SARS-CoV-2 (COVID-19) Membrane antibody can be stored at 4 ˚ C for three months and -20 ˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG

M

Membrane protein

Severe acute respiratory syndrome coronavirus 2

Zhu et al. N Engl J Med. 2020 Feb 20;382 (8) :727-733.

Kiyotani et al. J Hum Genet. 2020 Jul;65 (7) :569-575

Neuman et al. J Struct Biol. 2011;174 (1) :11–22.

Liu et al. J Infect Dis. 2010;202 (8) :1171-80.

SARS-CoV-2/SARS-CoV Matrix Antibody: SARS-CoV-2 Matrix protein, SARS Matrix protein, Membrane protein, E1 glycoprotein, M protein

ELISA, IHC

1800455127

Liquid